Exciting News for Stroke Patients in Québec!

Government Initiative to Evaluate PoNS Therapy Benefits

NEWTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE)

Helius Medical Technologies, Inc. has recently received a Letter of Intent from the Québec Ministry of Health and Social Services to purchase PoNS devices for five sites in five separate administrative regions within Québec. This government-funded initiative aims to evaluate the benefits of PoNS Therapy™ when used by patients who have suffered the effects of stroke.

This news is a game-changer for stroke patients in Québec, as PoNS Therapy™ has shown promising results in improving balance, walking, and overall quality of life for individuals recovering from a stroke. By providing these devices to at least five sites across the province, more patients will have access to this innovative therapy and the opportunity to expedite their recovery process.

PoNS Therapy™ works by stimulating the tongue with electrical signals, which in turn activates various parts of the brain responsible for motor function and balance. This novel approach to treating the effects of stroke has garnered attention in the medical community for its effectiveness and potential to revolutionize rehabilitation practices.

With the support of the Québec Ministry of Health and Social Services, Helius Medical Technologies, Inc. is one step closer to making PoNS Therapy™ more widely available to stroke patients in need. This partnership highlights the importance of innovation and collaboration in improving healthcare outcomes and quality of life for individuals with neurological conditions.

How Will This Impact Me?

If you or a loved one has experienced a stroke and are currently undergoing rehabilitation, the availability of PoNS Therapy™ in Québec could offer a new and effective treatment option. By incorporating this innovative technology into your recovery plan, you may experience improvements in balance, walking, and overall motor function, leading to a quicker and more comprehensive recovery process.

How Will This Impact the World?

The adoption of PoNS Therapy™ in Québec represents a significant advancement in the field of neurological rehabilitation. By demonstrating the benefits of this innovative treatment approach through a government-funded initiative, other regions and healthcare systems around the world may be inspired to incorporate PoNS Therapy™ into their own practices. This global recognition and acceptance of PoNS Therapy™ could pave the way for enhanced rehabilitation outcomes and improved quality of life for stroke patients worldwide.

Conclusion

The partnership between Helius Medical Technologies, Inc. and the Québec Ministry of Health and Social Services marks a significant milestone in the advancement of neurological rehabilitation. By providing PoNS Therapy™ to five sites in Québec, this government-funded initiative has the potential to positively impact the lives of stroke patients in the region and beyond. As we look towards a future where innovative technologies like PoNS Therapy™ are more readily accessible, we can envision a world where individuals recovering from stroke can achieve greater independence and quality of life.